Disulfide Core Cross-Linked PEGylated Polypeptide Nanogel Prepared by a One-Step Ring Opening Copolymerization of N-Carboxyanhydrides for Drug Delivery

A novel disulfide core cross‐linked PEGylated polypeptide nanogel has been synthesized by a one‐step ring opening copolymerization of γ‐benzyl L‐glutamate N‐carboxyanhydride and L‐cystine N‐carboxyanhydride using an amino group‐terminated poly(ethylene glycol) methyl ether as initiator. Characteriza...

Full description

Saved in:
Bibliographic Details
Published in:Macromolecular bioscience Vol. 11; no. 7; pp. 962 - 969
Main Authors: Xing, Tao, Lai, Bin, Ye, Xiaodong, Yan, Lifeng
Format: Journal Article
Language:English
Published: Weinheim WILEY-VCH Verlag 07-07-2011
WILEY‐VCH Verlag
Wiley-VCH
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A novel disulfide core cross‐linked PEGylated polypeptide nanogel has been synthesized by a one‐step ring opening copolymerization of γ‐benzyl L‐glutamate N‐carboxyanhydride and L‐cystine N‐carboxyanhydride using an amino group‐terminated poly(ethylene glycol) methyl ether as initiator. Characterization of products confirms the formation of a core cross‐linked PEGylated nanogel with disulfide linkages with a size of about 250 nm, and these studies also confirm that this nanogel can easily be broken by glutathione. Cell viability experiments show the good biocompatibility of the as‐prepared polymer. Studies relating to loading and controlled release of indomethacin under reduction‐sensitive conditions reveal that the nanogel is a good candidate for drug delivery systems. A novel disulfide core cross‐linked PEGylated polypeptide nanogel has been synthesized. The synthesis includes a one‐step ring opening copolymerization of γ‐benzyl L‐glutamate N‐carboxyanhydride and L‐cystine N‐carboxyanhydride using an amino group‐terminated poly(ethylene glycol) methyl ether as initiator. The nanogel is biocompatibile and displayed a high drug loading and controlled release of indomethacin.
Bibliography:ArticleID:MABI201000510
istex:00A435DB75648DEEBEDEB432BA7E16D8ED1BACA0
ark:/67375/WNG-BJ6P86RL-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1616-5187
1616-5195
1616-5195
DOI:10.1002/mabi.201000510